The Update of HIV-1 Prevalence and Incidence and Spatio-Temporal Analyses of HIV Recent Infection Among Four Sub-Groups in Sichuan, China During Surveillance Period Between 2016 and 2022

References

• Liu Z, Shi O, Yan Q, et al. Changing epidemiological patterns of HIV and AIDS in China in the post-SARS era identified by the nationwide surveillance system. BMC Infect Dis. 2018;18(1):700. doi:10.1186/s12879-018-3551-5
   PubMed Web of Science ®Google Scholar
• Yang H, Yiping L, Fang H, et al. Demographic Characteristics and Hot-Spot Areas of Recent Infections Among New HIV Diagnoses in Sichuan, China, Between 2018 and 2020. Infect Drug Resist. 2023;16:779–789. doi:10.2147/IDR.S394828
   PubMed Web of Science ®Google Scholar
• Wang L, Wang N. HIV/AIDS epidemic and the development of comprehensive surveillance system in China with challenges. Chin Med J. 2010;123(23):3495–3500.
   PubMed Web of Science ®Google Scholar
• Sun X, Wang N, Li D, et al. The development of HIV/AIDS surveillance in China. AIDS. 2007;21(Suppl 8):S33–S38. doi:10.1097/01.aids.0000304694.54884.06
   PubMedGoogle Scholar
• Ministry of Health of China, UNAIDS, WHO. 2005 Update on the HIV/AIDS Epidemic and Response in China. Beijing: Ministry of Health; 2006.
   Google Scholar
• State Council AIDS Working Committee Office, UN Theme Group on HIV/AIDS in China. A Joint Assessment of HIV/AIDS Prevention, Treatment and Care in China. Beijing: China Ministry of Health; 2004.
   Google Scholar
• Yang L, Chen M, Yanling M, et al. The changing trends of HIV-1 prevalence and incidence from sentinel surveillance of five sub-populations in Yunnan, China, 2001–2010. BMC Public Health. 2015;15(1):376. doi:10.1186/s12889-015-1722-5
   PubMedGoogle Scholar
• Yang H, Su L, Ye L, et al. Incidence rates of HIV-1 epidemics among 4 high risk groups in Sichuan province during 2011-2015. Zhonghua Liu Xing Bing Xue Za Zhi. 2017;38(12):1649–1654. doi:10.3760/cma.j.issn.0254-6450.2017.12.014
   PubMedGoogle Scholar
• Zhang F, Nie CL, Yuan FC, et al. HIV infection status and related factors in men who have sex with men in sentinel surveillance in Shanxi province, 2010, 2015 and 2020. Zhonghua Liu Xing Bing Xue Za Zhi. 2022;3(4):554–559. doi:10.3760/cma.j.cn112338-20210611-00469
   Google Scholar
• Bai JY, Ning TL, Zhou N, et al. HIV infection status and related factors in men who have sex with men in sentinel surveillance in Tianjin, 2016-2018. Zhonghua Liu Xing Bing Xue Za Zhi. 2019;40(9):1106–1110. doi:10.3760/cma.j.issn.0254-6450.2019.09.016
   PubMedGoogle Scholar
• Chinese center for disease control and prevention. The National AIDS Sentinel Surveillance Implementation Program Issued by Chinese Center for Disease Control and Prevention. Chinese center for disease control and prevention; 2022.
   Google Scholar
• Chinese center for disease control and prevention. The National AIDS Sentinel Surveillance Implementation Program Issued by Chinese Center for Disease Control and Prevention. Chinese center for disease control and prevention; 2017.
   Google Scholar
• Wei X, Liu X, Dobbs T, et al. Development of two avidity-based assays to detect recent HIV type 1 seroconversion using a multisubtype gp41 recombinant protein. AIDS Res Hum Retroviruses. 2010;26(1):1–11. doi:10.1089/aid.2009.0133
   PubMed Web of Science ®Google Scholar
• Duong YT, Qiu M, De AK, et al. Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies. PLoS One. 2012;7(3):e33328. doi:10.1371/journal.pone.0033328
   PubMed Web of Science ®Google Scholar
• Suligoi B, Massi M, Galli C, et al. Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay. J Acquir Immune Defic Syndr. 2003;32(4):424–428. doi:10.1097/00126334-200304010-00012
   PubMed Web of Science ®Google Scholar
• Chawla A, Murphy G, Donnelly C, et al. Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes. J Clin Microbiol. 2007;45(2):415–420. doi:10.1128/JCM.01879-06
   PubMed Web of Science ®Google Scholar
• Suligoi B, Galli C, Massi M, et al. Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. J Clin Microbiol. 2002;40(11):4015–4020. doi:10.1128/JCM.40.11.4015-4020.2002
   PubMed Web of Science ®Google Scholar
• Martró E, Suligoi B, González V, et al. Comparison of the avidity index method and the serologic testing algorithm for recent human immunodeficiency virus (HIV) seroconversion, two methods using a single serum sample for identification of recent HIV infections. J Clin Microbiol. 2005;43(12):6197–6199. doi:10.1128/JCM.43.12.6197-6199.2005
   PubMed Web of Science ®Google Scholar
• Schwarcz S, Kellogg T, McFarland W, et al. Differences in the temporal trends of HIV seroincidence and seroprevalence among sexually transmitted disease clinic patients, 1989-1998: application of the serological testing algorithm for recent HIV seroconversion. Am J Epidemiol. 2001;153(10):925–934. doi:10.1093/aje/153.10.925
   PubMed Web of Science ®Google Scholar
• Machado DM, Delwart EL, Diza RS, et al. Use of the sensitive/less-sensitive (detuned) EIA strategy for targeting genetic analysis of HIV-1 recently infected blood donors. AIDS. 2002;16(1):113–119. doi:10.1097/00002030-200201040-00014
   PubMed Web of Science ®Google Scholar
• Biomedical M. Maxim HIV-1 Limiting Antigen Avidity EIA, Single Well Avidity Enzyme Immunoassay for Detection of Recent HIV-1 Infection. Rockville, Maryland USA: Maxim Biomedical, Inc; 2013.
   Google Scholar
• UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance. When and How to Use Assays for Recent Infection to Estimate HIV Incidence at a Population Level. ISBN 978 92 4 150167 5 (NLM Classififi Cation: WC 503.41). Avenue Appia 20 1211 Geneva 27 Switzerland: World Health Organization Department of HIV/AIDS; 2011.
   Google Scholar
• UNAIDS/WHO Working Group on Global HIV/AIDS/STI Surveillance. Guidelines for Measuring National HIV Prevalence in Population-Based Surveys. Geneva: UNAIDS/WHO; 2005. Available from: http://data.unaids.org/pub/manual/2005/20050101_gs_guidemeasuringpopulation_en.pdf. Accessed January 12, 2011.
   Google Scholar
• Chinese center for disease control and prevention. The Operations Manual for Estimating HIV-1 Incidence Using a Laboratory Assay Issued by Chinese Center for Disease Control and Prevention. Chinese center for disease control and prevention; 2011.
   Google Scholar
• General Office of the State Council of the People’s Republic of China.Notice on the Issuance of the Thirteenth Five-Year Plan of Action for Curbing and Preventing AIDS in China. Government of China; 2017. Available from: http://www.gov.cn/zhengce/content/2017-02/05/content_5165514.htm. Accessed September 29, 2011.
   Google Scholar
• National Health Commission of the People’s Republic of China. Notice on the issuance of the Implementation plan for HIV/AIDS prevention (2019-2022); 2019. Available from: www.gov.cn/zhengce/zhengceku/2019-11/13/content_5451669.htm. Accessed September 28, 2023.
   Google Scholar
• Kanwugu ON, Adadi P. HIV/SARS-CoV-2 coinfection: a global perspective. J Med Virol. 2021;93(2):726–732. doi:10.1002/jmv.26321
   PubMed Web of Science ®Google Scholar
• National Health Commission of the People’s Republic of China. Guidance for Corona Virus Disease 2019(first edition); 2020. Available from: www.gov.cn/zhengce/zhengceku/2020-01/23/content_5471857.htm. Accessed September 28, 2023.
   Google Scholar
• European Centre for Disease Prevention and Control. Questions and answers on COVID-19: prevention; 2019. Available from: https://www.ecdc.europa.eu/en/covid-19/questions-answers/questions-answers-prevention. Accessed September 28, 2023.
   Google Scholar
• Winter BL, Hovaguimian F, Kouyos RD, et al. Changes in mental and sexual health among MSM using HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: longitudinal analysis of the SwissPrEPared cohort study. Swiss Med Wkly. 2022;152:w30192. doi:10.4414/SMW.2022.w30192
   PubMed Web of Science ®Google Scholar
• Pampati S, Emrick K, Siegler AJ. Changes in Sexual Behavior, PrEP adherence, and Access to Sexual Health Services Because of the COVID-19 Pandemic Among a Cohort of PrEP-Using MSM in the South. J Acquir Immune Defic Syndr. 2021;87(1):639–643. doi:10.1097/QAI.0000000000002640
   PubMed Web of Science ®Google Scholar
• Holtmann N, Edimiris P, Andree M, et al. Assessment of SARS-CoV-2 in human semen-a cohort study. Fertil Steril. 2020;114(2):233–238. doi:10.1016/j.fertnstert.2020.05.028
   PubMed Web of Science ®Google Scholar
• Yang M, Chen S, Huang B, et al. Pathological findings in the testes of COVID-19 patients: clinical implications. Eur Urol Focus. 2020;6(5):1124–1129. doi:10.1016/j.euf.2020.05.009
   PubMedGoogle Scholar
• Sanchez TH, Zlotorzynska M, Rai M, Baral SD. Characterizing the Impact of COVID-19 on Men Who Have Sex with Men Across the United States in April, 2020. AIDS Behav. 2020;24(7):2024–2032. doi:10.1007/s10461-020-02894-2
   PubMed Web of Science ®Google Scholar
• Vasylyeva TI, Smyrnov P, Strathdee S, Friedman SR. Challenges posed by COVID-19 to people who inject drugs and lessons from other outbreaks. J Int AIDS Soc. 2020;23(7):e25583. doi:10.1002/jia2.25583
   PubMed Web of Science ®Google Scholar
• Ma Y, Li ZZ, Zhang KX, et al. Identification of HIV infection among drug users in China. Zhonghua Liu Xing Bing Xue Za Zhi. 1990;11:184–185.
   Google Scholar
• Ruan Y, Qin G, Liu S, et al. HIV Incidence and Factors Contributed to Retention in a 12-Month Follow-up Study of Injection Drug Users in Sichuan Province, China. J Acquir Immune Defic Syndr. 2005;39(4):459–463. doi:10.1097/01.qai.0000152398.47025.0f
   PubMed Web of Science ®Google Scholar
• Beyrer C, Razak MH, Lisam K, et al. Overland heroin trafficking routes and HIV-1 spread in south and South-East Asia. AIDS. 2000;14(1):75–83. doi:10.1097/00002030-200001070-00009
   PubMed Web of Science ®Google Scholar
• Lin L, Jia M, Yanling M, et al. The changing face of HIV in China. Nature. 2008;455(7213):609–611. doi:10.1038/455609a
   PubMed Web of Science ®Google Scholar
• Yifei H, Liang S, Zhu J, et al. Factors Associated with Recent Risky Drug Use and Sexual Behaviors among Drug Users in Southwestern China. J AIDS Clin Res. 2011;2(120):2155–6113-2–120. doi:10.4172/2155-6113.1000120
   Google Scholar
• Yin L, Qin G, Qian H-Z, et al. Continued spread of HIV among injecting drug users in southern Sichuan Province, China. Harm Reduct J. 2007;4(1):6. doi:10.1186/1477-7517-4-6
   PubMedGoogle Scholar
• Li J, Ha TH, Zhang C, Liu H. The Chinese government’s response to drug use and HIV/AIDS: a review of policies and programs. Harm Reduct J. 2010;7(1):4. doi:10.1186/1477-7517-7-4
   PubMedGoogle Scholar
• Pang L, Hao Y, Mi G, et al. Effectiveness of first eight methadone maintenance treatment clinics in China. Aids AIDS. 2007;21(Suppl 8):S103–7. doi:10.1097/01.aids.0000304704.71917.64
   PubMed Web of Science ®Google Scholar
• Yin W, Hao Y, Sun X, et al. Scaling up the national methadone maintenance treatment program in China: achievements and challenges. Int J Epidemiol. 2010;2(Suppl 2):ii29–37. doi:10.1093/ije/dyq210
   Google Scholar
• Farhoudian A, Radfar SR, Mohaddes Ardabili H, et al. A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic. Front Psychiatry. 2021;12:646206. doi:10.3389/fpsyt.2021.646206
   PubMed Web of Science ®Google Scholar
• Zolopa C, Hoj S, Bruneau J, et al. A rapid review of the impacts of “Big Events” on risks, harms, and service delivery among people who use drugs: implications for responding to COVID-19. Int J Drug Policy. 2021;92:103127. doi:10.1016/j.drugpo.2021.103127
   PubMed Web of Science ®Google Scholar
• Joint United Nations Programme on HIV/AIDS. Delivering as one UN:The UN Joint Programme on AIDS in China 2018–2019. Available from: http://www.unaids.org.cn/pics/20181128171427.pdf. Accessed April 9, 2019.
   Google Scholar
• Li L, Wei D, Hsu W-L, et al. CRF07_BC strain dominates the HIV-1 epidemic in injection drug users in Liangshan Prefecture of Sichuan, China. AIDS Res Hum Retroviruses. 2015;31(5):479–487. doi:10.1089/AID.2014.0120
   PubMed Web of Science ®Google Scholar
• Zhu C, Zhou Y, Song X, et al. Review on the influence factors of AIDS epidemic and control in Liangshan Prefecture Sichuan Province of China. Fudan Uni J Med Sci. 2015;42:675–679.
   Google Scholar
• Liu Z, Tang X, Liu Y, et al. HIV Prevention and Health Poverty Alleviation – liangshan Prefecture, Sichuan Province, China, 2017-2020. China CDC Wkly. 2021;3(48):1031–1035. doi:10.46234/ccdcw2021.250
   PubMedGoogle Scholar
• Smith K, Bartlett N, Wang N. A harm reduction paradox: comparing China’s policies on needle and syringe exchange and methadone maintenance. Int J Drug Policy. 2012;23(4):327–332. doi:10.1016/j.drugpo.2011.09.010
   PubMed Web of Science ®Google Scholar
• Gill B, Okie S. China and HIV – a window of opportunity. N Engl J Med. 2007;356(18):1801–1805. doi:10.1056/NEJMp078010
   PubMed Web of Science ®Google Scholar
• Wang QQ, Chen XS, Yin YP, et al. HIV/STD pattern and its associated risk factors among male STD clinic attendees in China: a foci for HIV intervention. BMC Public Health. 2011;11:955. doi:10.1186/1471-2458-11-955
   PubMed Web of Science ®Google Scholar
• Zhang H, Hsieh E, Wang L, et al. HIV/AIDS Among Female Sex Workers in China: epidemiology and Recent Prevention Strategies. Curr HIV/AIDS Rep. 2020;17(2):151–160. doi:10.1007/s11904-019-00477-y
   PubMed Web of Science ®Google Scholar
• Zhao P, Tang W, Cheng H, et al. Uptake of provider-initiated HIV and syphilis testing among heterosexual STD clinic patients in Guangdong, China: results from a cross-sectional study. BMJ Open. 2020;10(12):e041503. doi:10.1136/bmjopen-2020-041503
   PubMed Web of Science ®Google Scholar
• Xiao Z, Noar SM, Zeng L. Systematic review of HIV prevention interventions in China: a health communication perspective. Int J Public Health. 2014;59(1):123–142. doi:10.1007/s00038-013-0467-0
   PubMed Web of Science ®Google Scholar
• Yuan FS, Liu L, Liu LH, et al. Epidemiological and spatiotemporal analyses of HIV/AIDS prevalence among older adults in Sichuan, China between 2008 and 2019: a population-based study. Int J Infect Dis. 2021;105:769–775. doi:10.1016/j.ijid.2021.02.077
   PubMed Web of Science ®Google Scholar
• Li W, Jiang J, Su J, et al. Commercial sexual behaviors among male rural-to-urban migrants in Western China: implications for HIV prevention. Asia Pac J Public Health. 2017;29(5):388–400. doi:10.1177/1010539517709029
   PubMed Web of Science ®Google Scholar
• Wang Y, Lu R, Wu G, et al. Changing trends of HIV, syphilis, and hepatitis c among male migrant workers in Chongqing, China: nine consecutive cross-sectional surveys, 2010–2018. Int J Environ Res Public Health. 2020;17(3):875. doi:10.3390/ijerph17030875
   PubMed Web of Science ®Google Scholar
• Ling S, Liang S, Hou X, et al. Impact of worker emigration on HIV epidemics in labour export areas: a molecular epidemiology investigation in Guangyuan, China. Sci Rep. 2018;8(1):16046. doi:10.1038/s41598-018-33996-6
   PubMedGoogle Scholar
• Yuan F-S, Liu L, Su L, Zeng Y-L, Liang S. The related factors of new HIV infection among older men in Sichuan, China: a case-control study. Epidemiol Infect. 2022;150:e156. doi:10.1017/S0950268822001352
   PubMed Web of Science ®Google Scholar
• Wang X, Lan G, Shen Z, et al. HIV and syphilis prevalence trends among men who have sex with men in Guangxi, China: yearly cross-sectional surveys, 2008–2012. BMC Infect Dis. 2014;14(1):367. doi:10.1186/1471-2334-14-367
   PubMedGoogle Scholar
• Zhou Y, Ding Y, Gu K, et al. Motivations for sexual risk behaviors among older men in Shanghai, China: a qualitative study. BMC Public Health. 2014;14(1):802. doi:10.1186/1471-2458-14-802
   PubMedGoogle Scholar
• Zhou C, Liang S, Yiping L, et al. Characterization of HIV-1 molecular epidemiology and transmitted drug-resistance in newly diagnosed HIV-infected patients in Sichuan, China. BMC Infect Dis. 2022;22:602. doi:10.1186/s12879-022-07576-z
   PubMed Web of Science ®Google Scholar
• Yuan D, Bin Y, Liang S, et al. HIV-1 genetic transmission networks among people living with HIV/AIDS in Sichuan, China: a genomic and spatial epidemiological analysis. Lancet Reg Health West Pac. 2021;18:100318. doi:10.1016/j.lanwpc.2021.100318
   PubMedGoogle Scholar
• Zhou C, Kang R, Liang S, et al. Risk Factors of Drug Resistance and the Potential Risk of HIV-1 Transmission of Patients with ART Virological Failure: a Population-Based Study in Sichuan, China. Infect Drug Resist. 2021;14:5219–5233. doi:10.2147/IDR.S334598.eCollection2021
   PubMed Web of Science ®Google Scholar
• Zhang W, Xu -J-J, Zou H, Zhang J, Wang N, Shang H. HIV incidence and associated risk factors in men who have sex with men in Mainland China: an updated systematic review and meta-analysis. Sex Health. 2016;13(4):373. doi:10.1071/SH16001
   Web of Science ®Google Scholar
• Yang H, Ye L, Su L. An analysis on incidence of HIV-1 epidemics among men who have sex with men in Sichuan Province during 2011-2015. Zhonghua Yu Fang Yi Xue Za Zhi. 2019;53(3):327–329. doi:10.3760/cma.j.issn.0253-9624.2019.03.018
   PubMedGoogle Scholar
• Nkambule RN-BH, Mnisi Z, Ao TT, et al. Substantial progress in confronting the HIV epidemic in Swaziland: first evidence of national impact. 9th IAS Conference on HIV Science 2017; Paris, France. p. 564.
   Google Scholar
• Nsanzimana S, Nshogoza Rwibasira G, Sewava Malamba S, et al. HIV incidence and prevalence among adults aged 15-64 years in Rwanda: results from the Rwanda Population-based HIV Impact Assessment (RPHIA) and District-level Modeling, 2019. Int J Infect Dis. 2022;116:245–254. doi:10.1016/j.ijid.2022.01.032
   PubMed Web of Science ®Google Scholar
• Nkambule R, PhilipID NM, Reid G, et al. HIV incidence, viremia, and the national response in Eswatini: two sequential population-based surveys. PLoS One. 2021;16(12):e0260892. doi:10.1371/journal.pone.0260892
   PubMed Web of Science ®Google Scholar
• Yang S, Alice PYC, Lin Q. HIV epidemics in Shenzhen and Chongqing, China. PLoS One. 2018;13(2):e0192849. doi:10.1371/journal.pone.0192849
   PubMed Web of Science ®Google Scholar
• Dong M-J, Peng B, Liu Z-F. The prevalence of HIV among MSM in China: a large-scale systematic analysis. BMC Infect Dis. 2019;19(1):1000. doi:10.1186/s12879-019-4559-1
   PubMed Web of Science ®Google Scholar
• Notice of the Office of the Luzhou Municipal People’s Government on the issuance of the thirteenth five-year plan of action for curbing and preventing AIDS in Luzhou. Government of Luzhou; 2018. Available from: http://wjw.luzhou.gov.cn/zwgk/lzyj/bmwj/zcwj/content_552514. Accessed July 18, 2021.
   Google Scholar
• Implementation opinions of the Office of the Committee on Prevention and Treatment of Major Infectious Diseases in Luzhou on further strengthening the management of HIV antiretroviral treatment and follow-up. Government of Luzhou. Available from: http://wjw.luzhou.gov.cn/zwgk/lzyj/bmwj/zcwj/content_537126. Accessed September 15, 2018.
   Google Scholar
• RenN, YuanshengL, WangR, et al.The Distribution of HIV and AIDS Cases in Luzhou, China, From 2011 to 2020. JMIR Public Health Surveill. 2022;8(6):e37491. doi:10.2196/37491
   PubMedGoogle Scholar